MedPath

Hospital Intensive Monitoring of Adverse Drug Reactions of Qingkailing Injection In The Next Two Years

Completed
Conditions
Adverse Drug Reactions
Adverse Drug Events
Interventions
Registration Number
NCT01764204
Lead Sponsor
China Academy of Chinese Medical Sciences
Brief Summary

To highlight the incidence of adverse reactions of Qingkailing Injection.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30840
Inclusion Criteria
  • all the patients treated by Qingkailing Injection in the certain centers(hospitals) in the next 2 years.
  • in accordance with ethics requirements.
Exclusion Criteria
  • none.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Qingkailing InjectionQingkailing Injection-
Primary Outcome Measures
NameTimeMethod
incidence of severe adverse drug reactions2 years
Secondary Outcome Measures
NameTimeMethod
incidence of adverse drug reactions2 years

Trial Locations

Locations (48)

National Defense University Hospital of People's Liberation Army

🇨🇳

Beijing, Beijing, China

Ren'ai Hospital

🇨🇳

Shenzhen, Guangdong, China

Chinese Medicine Hospital of Deqing County

🇨🇳

Zhaoqing, Guangdong, China

Chinese Medicine Hospital of Gaoyang County

🇨🇳

Baoding, Hebei, China

Gaoyang County Hospital

🇨🇳

Baoding, Hebei, China

The Third People's Hospital of Xiong County

🇨🇳

Baoding, Hebei, China

Chinese Medicine Hospital of Xiong County

🇨🇳

Baoding, Hebei, China

Chinese Medicine Hospital of Tang County

🇨🇳

Baoding, Hebei, China

People's Hospital of Tang County

🇨🇳

Baoding, Hebei, China

Chinese Medicine Hospital of Handan City

🇨🇳

Handan, Hebei, China

Scroll for more (38 remaining)
National Defense University Hospital of People's Liberation Army
🇨🇳Beijing, Beijing, China

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.